Chief Information Officer
Mohamad has over 20 years of global experience in Information Technology (IT), Enterprise Business Systems, and business processes. As Chief Information Officer (CIO), Mohamad is responsible for overseeing the operational and strategic aspects of the company’s IT infrastructure, Business Process Transformation, IT-related products, process and application development. Prior to TrialAssure, Mohamad held several leadership positions in the industry and led multiple IT and business systems transformation initiatives. He has established governance over key enterprise business processes, as well as led the formation of cloud strategy and architecture.
His expertise extends to ISMS areas, including quality certifications. He is proficient and experienced at emerging technology needs within the pharmaceutical industry, including IT infrastructure requirements to support clinical trial transparency.
Mohamad holds a Master of Science in Computer and Information Systems from the University of Detroit Mercy, and a bachelor’s degree in Computer Information Systems from The Detroit College of Business.
Product Solutions Manager
Zach Weingarden is a Product Solutions Manager with over eight years of experience in the healthcare and CRO arena. Mr. Weingarden has managed software implementations, including TrialAssure™, as well as EMR systems in fast-paced and demanding healthcare, research, biotech and pharma environments. He is adept at analyzing business workflows and aids in the design, configuration and testing of TrialAssure™ software that aligns with organizational needs and objectives. Demonstrated ability to manage application developers, technical services representatives, and client analyst teams to ensure projects met strict deadlines and adhere to budget constraints. Mr. Weingarden holds a Master of Science in Biomedical Engineering concentrating in Biotechnology and a Bachelor of Science in Industrial and Operations Engineering.
Executive Director, Global Project & Account Management
Kelly has more than 18 years of clinical research experience in the pharmaceutical and CRO arenas holding positions within clinical data services, clinical operations, regulatory compliance and project management departments. Kelly has successfully led cross-functional teams through the execution of global Phase 1 through Phase 4 clinical trials while managing studies on time and under budget. Kelly has initiated long term partnerships with biotech companies and large multinational pharmaceutical organizations, developing strategies to support their short and long term goals. This support extends to due diligence activities, compliance auditing, and establishing resource and technology strategies to meet the emerging needs in the area of data transparency.
As the Executive Director, Global Project and Account Management, Kelly is responsible for all client accounts and oversight of the project management function. Kelly has helped establish relationships within various lines at the client end to ensure a harmonized approach to service delivery.
Kelly completed undergraduate degrees in biology and mathematics leading to a Master’s in Clinical Research Design and Statistical Analysis from the University of Michigan.
Director, EU Operations & Business Development
Alan has over 20 years of experience within the global pharmaceutical environment, working across development, consultancy and clinical trial transparency and disclosure services.
Alan is a member of the global operations team specializing in markets in the UK and other parts of Europe. He has led the development and implementation of new product strategies on behalf of top pharma in this region. In addition, Alan has successfully worked with these companies to develop outsourcing strategies (technology plus resourcing) that will meet the strict requirements for clinical trial disclosure and reporting to global registries.
Alan holds a Postgraduate Diploma in Information Technology and Society, and a Bachelor’s degree in Physiology and Biochemistry from the University of Southampton.